Zobrazeno 1 - 10
of 76
pro vyhledávání: '"MAYA FAYFMAN"'
Autor:
Maya Fayfman, Andrew T. Gewirtz, Clara Delaroque, Gerardo Blanco, Seid Gibanica, Shanthi Srinivasan, Benoit Chassaing
Publikováno v:
Metabolism Open, Vol 20, Iss , Pp 100256- (2023)
Aims: Metformin is the broadly accepted the first-line medication for diabetes. Its use, however, is limited by gastrointestinal side effects present in approximately 25% of patients. This study aimed to better understand the interplay between metfor
Externí odkaz:
https://doaj.org/article/d80ead4d7bf4402684a436eb05363782
Publikováno v:
AACE Clinical Case Reports, Vol 4, Iss 2, Pp 143-146 (2018)
ABSTRACT: Objective: To discuss a case of adrenal insufficiency (AI) caused by heparin-induced thrombocytopenia (HIT) and subsequent adrenal hemorrhage.Methods: We describe the case of a patient who developed postoperative HIT, which went undetected
Externí odkaz:
https://doaj.org/article/8f500ca26d1746c5a4ce5f641b470e1c
Autor:
Saumeth Cardona, Priyathama Vellanki, Maya Fayfman, Rodolfo J Galindo, Francisco J Pasquel, Katerina Tsegka, Limin Peng, Sol Jacobs, Michael Halkos, Robert A Guyton, Vinod H Thourani, Guillermo Umpierrez
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 7, Iss 1 (2019)
Aims To determine if treatment with sitagliptin, a dipeptidyl peptidase-4 inhibitor, can prevent stress hyperglycemia in patients without diabetes undergoing coronary artery bypass graft (CABG) surgery.Methods We conducted a pilot, double-blinded, pl
Externí odkaz:
https://doaj.org/article/84fcff3743514cd6b09b39e428c2d33c
Publikováno v:
Seminars in Vascular Surgery. 36:19-32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86f8ae7f3f43cc0574bc148e2464df89
https://doi.org/10.1053/j.semvascsurg.2023.01.002
https://doi.org/10.1053/j.semvascsurg.2023.01.002
Autor:
Elias K. Spanakis, Agustina Urrutia, Rodolfo J. Galindo, Priyathama Vellanki, Alexandra L. Migdal, Georgia Davis, Maya Fayfman, Thaer Idrees, Francisco J. Pasquel, Walkiria Zamudio Coronado, Bonnie Albury, Emmenlin Moreno, Lakshmi G. Singh, Isabel Marcano, Sergio Lizama, Chikara Gothong, Kashif Munir, Catalina Chesney, Rebecca Maguire, William H. Scott, M. Citlalli Perez-Guzman, Saumeth Cardona, Limin Peng, Guillermo E. Umpierrez
Publikováno v:
Diabetes Care. 45:2369-2375
OBJECTIVE The efficacy and safety of continuous glucose monitoring (CGM) in adjusting inpatient insulin therapy have not been evaluated. RESEARCH DESIGN AND METHODS This randomized trial included 185 general medicine and surgery patients with type 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::051ef7083cda3821f70bdec608c9ba74
https://doi.org/10.2337/dc22-0716
https://doi.org/10.2337/dc22-0716
Autor:
Marcos C. Schechter, Yutong Yao, Manish Patel, Rebecca Andruski, Saira Rab, Jordan R. Wong, Gabriel Santamarina, Maya Fayfman, Ravi Rajani, Russell R. Kempker
Publikováno v:
Infectious Diseases in Clinical Practice. 31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::300a75b31505afe0666a2e1a8b5ba500
https://doi.org/10.1097/ipc.0000000000001219
https://doi.org/10.1097/ipc.0000000000001219
Autor:
Priyathama Vellanki, David W. Lam, Katherine R. Tuttle, Rodolfo J. Galindo, Maria A. Urrutia, Karla Walkiria Zamudio-Coronado, Limin Peng, Georgia Davis, Maya Fayfman, Citlalli Perez-Guzman, Radica Z. Alicic, Guillermo E. Umpierrez, Alexandra Migdal, Saumeth Cardona, Francisco J. Pasquel
Publikováno v:
Diabetes Obes Metab
AIMS: Limited data exists about the use of insulin degludec in the hospital. This multicentre, non-inferiority, open-label, prospective randomised trial compared the safety and efficacy of insulin degludec-U100 and glargine-U100 for the management of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fed328c46d45646e10962252f82f616
https://doi.org/10.1111/dom.14544
https://doi.org/10.1111/dom.14544
Autor:
Gianluca Iacobellis, Maria A. Urrutia, Patricia C. Gomez, Juan D. Palacios, Priyathama Vellanki, Karla W. Z. Coronado, Georgia Davis, Francisco J. Pasquel, Rodolfo J. Galindo, Limin Peng, Bonnie S. Albury, Isabel Anzola, Javier M. Farias, Guillermo E. Umpierrez, Ajay Chaudhuri, Mireya C. Perez-Guzman, Maya Fayfman, Saumeth Cardona, Alexandra Migdal
Publikováno v:
Diabetes Obes Metab
AIM: To compare a glucagon-like peptide-1 receptor agonist with basal insulin at hospital discharge in patients with uncontrolled type 2 diabetes in a randomized clinical trial. METHODS: A total of 273 patients with glycated haemoglobin (HbA1c) 7%–
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7952ea0efe3975583959afae340622a8
https://doi.org/10.1111/dom.14347
https://doi.org/10.1111/dom.14347
Autor:
Guillermo E. Umpierrez, Limin Peng, Alexandra Migdal, Maya Fayfman, Georgia M Davis, Francisco J Pasquel, Maria A. Urrutia, Rodolfo J Galindo, Saumeth Cardona, Priyathama Vellanki
Objective: Administration of supplemental sliding scale insulin (SSI) for correction of hyperglycemia in non-ICU patients with type 2 diabetes is frequently used with basal-bolus insulin regimens. This non-inferiority randomized controlled trial test
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f98caecd4061ed52c8e0e40abb570a
https://doi.org/10.2337/figshare.19763455
https://doi.org/10.2337/figshare.19763455
Autor:
MAYA FAYFMAN, SHANTHI SRINIVASAN, GUILLERMO E. UMPIERREZ, GERARDO BLANCO, ANDREW GEWIRTZ, BENOIT CHASSAING
Publikováno v:
Diabetes. 71
Metformin is the broadly accepted the first-line medication for diabetes. Its use, however, is limited by gastrointestinal side effects, which occur in approximately 25% of patients. We performed a cross-sectional study assessing microbiota compositi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fd1a687e5f0473aab7d6d96795d490c
https://doi.org/10.2337/db22-847-p
https://doi.org/10.2337/db22-847-p